BPC-157 Capsules 500mcg Oral research format of Body Protection Compound peptide
Testosterone Replacement Therapy: Nausea or vomiting Infertility or decreased sperm count Testicular shrinkage Worsening of obstructive sleep apnea Increase in cholesterol levels Abnormal spike in blood sugar levels, which can increase the risk of developing Type 2 diabetes Yellowing of the skin or around your eyes Uncomfortable swelling or enlargement of breast tissue (gynecomastia) Redness, warmth around lower leg area Unusual increase in red blood cell count, which can result in high blood pressure, joint/muscle pain, trouble with eyesight or thrombosis (blood clotting) Frequent need to urinate Fluid retention Acne or oily skin Headaches Lumps or hardening around injection site Clomid: Headaches Nausea Bloating Mood swings Diminished sex drive Sperm counts decrease (can be reversed by changing Clomid to another type of estrogen blocker, such as tamoxifen.) Acne Chest tenderness Blurry vision Weight gain High blood pressure (hypertension) Altered taste Asthma Flushing Excess thirst Joint aches Enclomiphene Libido issues Acne A temper if levels get too high Mood swings Depression Mood irritability Anxiety Gynecomastia Headache Nausea Diarrhea Dizziness Common Cold Hot flush Joint pain NOTE: Enclomiphene is the purified isomer of Clomid (Clomiphene Citrate)
In my over 45 years experience with P.A I have found that exercise and P.A don't mix so when I was diagnosed with Type 2 diabetes and told to exercise I laughed, but compromised by buying an electrical powered mini exercise bike I can use in my armchair and regulate time, distance and difficulty by remote control
She also referenced an Italian vegan woman who had been taking a prenatal containing B12 during pregnancy who gave birth to a B12-deficient baby who is now permanently disabled, as well as vegan babies in Australia who have died of B12 deficiency
Red Alpha Labs BPC-157 is supplied as a lyophilized research peptide for laboratory and in-vitro research use only
Most protocols target 5 mg/mL, which allows precise dose drawing on a standard insulin syringe without requiring very small volumes (which increase dosing error) or very large volumes (which can cause injection-site discomfort)
